FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999825096> ?p ?o ?g. }

• W2999825096 endingPage "S599" @default.
• W2999825096 startingPage "S598" @default.
• W2999825096 abstract "Abstract Background Patients with inflammatory bowel disease (IBD), such as ulcerative colitis (UC) and Crohn’s disease (CD) are at increased risk of developing gastrointestinal (GI) malignancies. The aim of this study is to assess the risk of malignancies in IBD patients and the impact of cancer screening according to the ECCO guidelines in a tertiary referral centre. Methods We retrospectively analysed the electronic database of all IBD patients followed by the IBD Centre of Humanitas Research Hospital, Milan, from January 2010 to October 2019, and collected all new diagnoses of solid and haematological tumours since 2010. The annual standardised incidence rate (SIR), rate of mortality and early cancer diagnosis were calculated and a descriptive analysis of drug exposure, disease duration, family history of any cancer, smoking habits was made. Results We included 5239 patients, with a total 19820 patient-years follow-up. Eighty-four malignancies in 81 patients were retrieved, 71 were included in the final analysis (38 CD, 32 UC, 31 females). Average age at tumour diagnosis was 52.9 years (range 19–78). 64% of patients were former or active smokers, 31% had a family history of cancer or IBD. Sixty-two per cent of patients were previously exposed or had 5-ASA at the time of cancer, 40% azathioprine, 43% anti-TNF or vedolizumab. The annual SIR for all kinds of malignancy was 0.358%. GI malignancies were the most frequent (n = 17, 23.9%, 47% UC, 53% in CD). Six over 8 GI tract malignancies in UC patients were found in the colon or rectum (mean disease duration 22.5 years), whereas in CD patients 5/9 were in the small-bowel (mean disease duration 7.0 years). Melanoma and breast cancer (n = 8 each) were the most common non-GI cancers, followed by prostate (n = 7) and bladder (n = 6). No significant difference in incidence was found between CD or UC. Non-Hodgkin lymphomas and leukaemia (3 and 1, respectively) only occurred in CD patients. Other tumours included thyroid (n = 5), lungs (n = 4), testicle (n = 3), ovary (n = 2), kidney (n = 2), head-nose-throat (n = 2), pancreas (n = 1), brain (n = 1), and non-melanoma skin cancer (n = 1). Death occurred in 11% of patients, 8 of them for late stage cancer. Only 2 were related to the concomitant IBD (1 colo-rectal and 1 anal cancer). In patients regularly screened according to the ECCO Guidelines (GI cancer, haematological and skin cancer), there was a significantly higher number of detection of early cancer (28 vs. 1, p = 0.003), although no differences in mortality rates were reported in the two groups (2 vs. 2, p = 0.10). Conclusion The overall incidence of cancer in our cohort was not different from the current literature available. Adherence to the ECCO Guidelines for cancer surveillance improves the detection of early cancer in IBD patients." @default.
• W2999825096 created "2020-01-23" @default.
• W2999825096 creator A5008725400 @default.
• W2999825096 creator A5014483659 @default.
• W2999825096 creator A5024251092 @default.
• W2999825096 creator A5039504189 @default.
• W2999825096 creator A5047563454 @default.
• W2999825096 creator A5053281667 @default.
• W2999825096 creator A5060056767 @default.
• W2999825096 creator A5074245235 @default.
• W2999825096 creator A5085303484 @default.
• W2999825096 date "2020-01-01" @default.
• W2999825096 modified "2023-10-17" @default.
• W2999825096 title "P747 Adherence to ECCO guidelines for cancer surveillance is associated to the detection of early cancer: A retrospective, single-centre, cohort study" @default.
• W2999825096 doi "https://doi.org/10.1093/ecco-jcc/jjz203.875" @default.
• W2999825096 hasPublicationYear "2020" @default.
• W2999825096 type Work @default.
• W2999825096 sameAs 2999825096 @default.
• W2999825096 citedByCount "0" @default.
• W2999825096 crossrefType "journal-article" @default.
• W2999825096 hasAuthorship W2999825096A5008725400 @default.
• W2999825096 hasAuthorship W2999825096A5014483659 @default.
• W2999825096 hasAuthorship W2999825096A5024251092 @default.
• W2999825096 hasAuthorship W2999825096A5039504189 @default.
• W2999825096 hasAuthorship W2999825096A5047563454 @default.
• W2999825096 hasAuthorship W2999825096A5053281667 @default.
• W2999825096 hasAuthorship W2999825096A5060056767 @default.
• W2999825096 hasAuthorship W2999825096A5074245235 @default.
• W2999825096 hasAuthorship W2999825096A5085303484 @default.
• W2999825096 hasBestOaLocation W29998250961 @default.
• W2999825096 hasConcept C120665830 @default.
• W2999825096 hasConcept C121332964 @default.
• W2999825096 hasConcept C121608353 @default.
• W2999825096 hasConcept C126322002 @default.
• W2999825096 hasConcept C167135981 @default.
• W2999825096 hasConcept C2776207728 @default.
• W2999825096 hasConcept C2776760755 @default.
• W2999825096 hasConcept C2777044582 @default.
• W2999825096 hasConcept C2778260677 @default.
• W2999825096 hasConcept C2778435480 @default.
• W2999825096 hasConcept C2779134260 @default.
• W2999825096 hasConcept C2779399171 @default.
• W2999825096 hasConcept C2779840525 @default.
• W2999825096 hasConcept C2780479503 @default.
• W2999825096 hasConcept C2781179581 @default.
• W2999825096 hasConcept C526805850 @default.
• W2999825096 hasConcept C61511704 @default.
• W2999825096 hasConcept C71924100 @default.
• W2999825096 hasConcept C72563966 @default.
• W2999825096 hasConceptScore W2999825096C120665830 @default.
• W2999825096 hasConceptScore W2999825096C121332964 @default.
• W2999825096 hasConceptScore W2999825096C121608353 @default.
• W2999825096 hasConceptScore W2999825096C126322002 @default.
• W2999825096 hasConceptScore W2999825096C167135981 @default.
• W2999825096 hasConceptScore W2999825096C2776207728 @default.
• W2999825096 hasConceptScore W2999825096C2776760755 @default.
• W2999825096 hasConceptScore W2999825096C2777044582 @default.
• W2999825096 hasConceptScore W2999825096C2778260677 @default.
• W2999825096 hasConceptScore W2999825096C2778435480 @default.
• W2999825096 hasConceptScore W2999825096C2779134260 @default.
• W2999825096 hasConceptScore W2999825096C2779399171 @default.
• W2999825096 hasConceptScore W2999825096C2779840525 @default.
• W2999825096 hasConceptScore W2999825096C2780479503 @default.
• W2999825096 hasConceptScore W2999825096C2781179581 @default.
• W2999825096 hasConceptScore W2999825096C526805850 @default.
• W2999825096 hasConceptScore W2999825096C61511704 @default.
• W2999825096 hasConceptScore W2999825096C71924100 @default.
• W2999825096 hasConceptScore W2999825096C72563966 @default.
• W2999825096 hasIssue "Supplement_1" @default.
• W2999825096 hasLocation W29998250961 @default.
• W2999825096 hasOpenAccess W2999825096 @default.
• W2999825096 hasPrimaryLocation W29998250961 @default.
• W2999825096 hasRelatedWork W1464824982 @default.
• W2999825096 hasRelatedWork W2001393134 @default.
• W2999825096 hasRelatedWork W2041940649 @default.
• W2999825096 hasRelatedWork W2050886412 @default.
• W2999825096 hasRelatedWork W2132711226 @default.
• W2999825096 hasRelatedWork W2158616326 @default.
• W2999825096 hasRelatedWork W2749325548 @default.
• W2999825096 hasRelatedWork W2783252011 @default.
• W2999825096 hasRelatedWork W3187606406 @default.
• W2999825096 hasRelatedWork W4223412371 @default.
• W2999825096 hasVolume "14" @default.
• W2999825096 isParatext "false" @default.
• W2999825096 isRetracted "false" @default.
• W2999825096 magId "2999825096" @default.
• W2999825096 workType "article" @default.